Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
GTXI [NASD]
GTX Inc.
Index- P/E- EPS (ttm)-0.67 Insider Own43.60% Shs Outstand75.15M Perf Week1.43%
Market Cap106.71M Forward P/E- EPS next Y-0.39 Insider Trans17.31% Shs Float22.09M Perf Month-19.32%
Income-42.10M PEG- EPS next Q-0.12 Inst Own9.50% Short Float21.71% Perf Quarter-27.92%
Sales- P/S- EPS this Y-3.10% Inst Trans-0.01% Short Ratio8.17 Perf Half Y-18.39%
Book/sh0.18 P/B7.89 EPS next Y9.30% ROA-144.80% Target Price1.50 Perf Year-71.26%
Cash/sh0.20 P/C7.26 EPS next 5Y0.00% ROE-190.30% 52W Range1.26 - 7.24 Perf YTD-13.94%
Dividend- P/FCF- EPS past 5Y14.10% ROI- 52W High-80.59% Beta1.25
Dividend %- Quick Ratio3.30 Sales past 5Y- Gross Margin- 52W Low11.51% ATR0.12
Employees32 Current Ratio3.30 Sales Q/Q- Oper. Margin- RSI (14)41.28 Volatility7.53% 8.32%
OptionableYes Debt/Eq0.00 EPS Q/Q23.50% Profit Margin- Rel Volume0.26 Prev Close1.42
ShortableYes LT Debt/Eq0.00 EarningsApr 28 Payout- Avg Volume587.20K Price1.40
Recom3.00 SMA20-4.78% SMA50-14.73% SMA200-35.53% Volume131,674 Change-1.06%
05-Apr-13Initiated Stifel Buy $7
14-Oct-11Initiated Rodman & Renshaw Mkt Outperform $7
20-Jul-11Initiated Wedbush Outperform $13
27-Oct-10Upgrade Rodman & Renshaw Mkt Underperform → Mkt Perform
26-May-10Reiterated Rodman & Renshaw Mkt Underperform $1.75 → $1.25
17-Mar-10Downgrade Rodman & Renshaw Mkt Perform → Mkt Underperform $1.75
26-Jan-09Reiterated Leerink Swann Mkt Perform $18 → $10
22-Jan-09Downgrade Rodman & Renshaw Mkt Outperform → Mkt Perform
23-May-08Downgrade Cowen & Co Outperform → Neutral
25-Mar-08Initiated Rodman & Renshaw Mkt Outperform $22
07-Nov-07Reiterated Lazard Capital Buy $28 → $31
06-Nov-07Reiterated Broadpoint Capital Buy $26 → $29
11-Oct-07Initiated Wachovia Outperform
13-Sep-07Initiated First Albany Buy $26
10-May-07Initiated Citigroup Hold $24
30-Apr-07Downgrade Leerink Swann Outperform → Mkt Perform
24-Apr-07Reiterated HSBC Securities Overweight $25 → $29
18-Apr-07Reiterated Lazard Capital Buy $25 → $28
18-Apr-07Reiterated AG Edwards Buy $23 → $28
26-Feb-07Reiterated Lazard Capital Buy $21 → $25
15-Apr-14 08:56AM  GTx Chief Scientific Officer James Dalton resigns at theflyonthewall.com
08:46AM  GTX INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
04-Apr-14 04:37PM  GTX INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
07:01AM  GTX INC /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
06:25AM  GTx Announces Departure of CEO Business Wire
25-Mar-14 01:23PM  NVIDIA announces Titan Z: a $3,000 graphics computing powerhouse at Engadget
19-Mar-14 07:47AM  Strength Seen in GTX (GTXI): Stock Moves 8.8% Higher Zacks
18-Mar-14 01:04PM  GTX INC /DE/ Financials EDGAR Online Financials +8.79%
12-Mar-14 04:32PM  GTX INC /DE/ Files SEC form 10-K, Annual Report EDGAR Online
06-Mar-14 05:14PM  GTX INC /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
05:05PM  GTx, Inc. Announces Closing of Private Placement Business Wire
05:05PM  GTx, Inc. Announces Closing of Private Placement
05-Mar-14 08:50AM  Narrower-than-Expected Q4 Loss at GTx Zacks
08:50AM  Narrower-than-Expected Q4 Loss at GTx
07:30AM  GTx Announces Webcast of Corporate Presentation at 26TH Annual ROTH Conference Business Wire
07:30AM  GTx Announces Webcast of Corporate Presentation at 26TH Annual ROTH Conference
04-Mar-14 04:17PM  GTX INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, EDGAR Online +5.95%
03:18PM  GTx's CEO Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha
03:18PM  GTx's CEO Discusses Q4 2013 Results - Earnings Call Transcript
09:00AM  GTx, Inc. Earnings Call scheduled for 9:00 am ET today CCBN
08:00AM  GTX INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
07:34AM  GTx, Inc. Earnings Call scheduled for 9:00 am ET today CCBN
07:07AM  Q4 2013 GTx, Inc. Earnings Release - Before Market Open CCBN
07:00AM  GTx Provides Corporate Update and Reports 2013 Financial Results Business Wire
07:00AM  GTx Provides Corporate Update and Reports 2013 Financial Results
06:30AM  GTx, Inc. Announces Pricing of Private Placement Business Wire
26-Feb-14 07:30AM  GTx Announces Webcast of Corporate Presentation at Cowen and Company 34th Annual Health Care Conference Business Wire
20-Feb-14 09:08PM  Nvidia Is About To Steal The Cryptocurrency Mining Crown From AMD at Forbes
19-Feb-14 10:49AM  NVIDIA Titan Black cards bring much improved specs, even crazier prices at Engadget
18-Feb-14 07:30AM  GTx, Inc. To Host Fourth Quarter and Full Year 2013 Financial Results Conference Call and Webcast Business Wire
10-Feb-14 07:02AM  GTX INC /DE/ Files SEC form 8-K, Regulation FD Disclosure EDGAR Online
04-Feb-14 07:30AM  GTx Announces Webcast of Corporate Presentation at Bio CEO & Investor Conference Business Wire
29-Jan-14 08:04AM  GTX INC /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
08:04AM  GTX INC /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits
07:30AM  Preliminary findings from the Phase 2 clinical trial of GTx-758 in men with castration resistant prostate cancer to be presented at ASCO Genitourinary Cancer Symposium Business Wire
07:30AM  Preliminary findings from the Phase 2 clinical trial of GTx-758 in men with castration resistant prostate cancer to be presented at ASCO Genitourinary Cancer Symposium
07-Jan-14 06:50AM  GTX Inc. (GTXI) Worth Watching: Stock Rises 7.2% Zacks
06:50AM  GTX Inc. (GTXI) Worth Watching: Stock Rises 7.2%
23-Dec-13 04:17PM  GTX INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
04:17PM  GTX INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers
19-Dec-13 02:48PM  5 Stocks Under $10 Set to Soar at TheStreet
02:48PM  5 Stocks Under $10 Set to Soar
12-Dec-13 07:30AM  GTx Presents on Enobosarm as Targeted Therapy for the Treatment of Androgen Receptor-Positive Breast Cancer at the San Antonio Breast Cancer Symposium Business Wire
07:30AM  GTx Presents on Enobosarm as Targeted Therapy for the Treatment of Androgen Receptor-Positive Breast Cancer at the San Antonio Breast Cancer Symposium
11-Dec-13 12:22PM  Digital Storm's first Steam Machine will be a $1,469 gaming PC The Verge -5.84%
12:22PM  Digital Storm's first Steam Machine will be a $1,469 gaming PC at The Verge
12:22PM  Digital Storm's first Steam Machine will be a $1,469 gaming PC
21-Nov-13 06:37AM  Investors are betting against GTx, Inc. (GTXI), Should You? Zacks
06:37AM  Investors are betting against GTx, Inc. (GTXI), Should You?
19-Nov-13 01:04PM  GTX INC /DE/ Financials EDGAR Online Financials
01:04PM  GTX INC /DE/ Financials
12-Nov-13 12:36PM  GTx's CEO Discusses Q3 2013 Results - Earnings Call Transcript at Seeking Alpha
12:36PM  GTx's CEO Discusses Q3 2013 Results - Earnings Call Transcript
09:00AM  GTx, Inc. Earnings Call scheduled for 9:00 am ET today CCBN
09:00AM  GTx, Inc. Earnings Call scheduled for 9:00 am ET today
08:55AM  GTx, Inc. Discusses Q2 2013 Results (Webcast) at Seeking Alpha
08:55AM  GTx, Inc. Discusses Q2 2013 Results (Webcast)
08:49AM  GTx, Inc. Earnings Call scheduled for 9:00 am ET today CCBN
07:07AM  Q3 2013 GTx, Inc. Earnings Release - Before Market Open CCBN
07:01AM  GTX INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
06:36AM  InPlay: GTX beats by $0.07; provides clinical updates on Enobosarm Briefing.com
06:30AM  GTx Provides Corporate Update and Reports Third Quarter 2013 Financial Results Business Wire
07-Nov-13 12:00PM  Nvidia Launches GTX 780 Ti -- Faster Than Titan For $300 Less at Forbes
04-Nov-13 10:46AM  We play with the Steam Machine, Valve's game console of the future at The Verge
29-Oct-13 07:30AM  GTx, Inc. To Host Third Quarter 2013 Financial Results Conference Call and Webcast Business Wire
28-Oct-13 10:44AM  Nvidia Issues Aggressive 33 Percent Price Drops For GeForce GTX 780, 770 Graphics Cards at Forbes
24-Oct-13 08:10AM  GTX Corp Partners with Aeris to Power a New Era of Personal Location Services and Wearable Technology Accesswire
08:02AM  GTX INC /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
07:31AM  InPlay: GTX presents results from Enobosarm POWER trials for the prevention and treatment of muscle wasting in patients with non-small cell lung cancer at 15th World Conference on Lung Cancer; Enobosarm had a significant effect on Lean Body Briefing.com
07:30AM  GTx Presents Results from Enobosarm POWER Trials for the Prevention and Treatment of Muscle Wasting in Patients with Non-Small Cell Lung Cancer at 15th World Conference on Lung Cancer Business Wire
21-Oct-13 01:00PM  NVIDIA's got a Shield 2 in the works with a next-gen Tegra heart, and why G-Sync is a big deal at Engadget
18-Oct-13 11:33AM  NVIDIA reveals the GTX 780 Ti, a new 'high-end enthusiast' GPU at Engadget
06-Oct-13 08:15AM  5 of Last Week's Biggest Losers at Motley Fool
04-Oct-13 03:55PM  Here's what's inside Valve's first Steam Machine prototypes at The Verge
01-Oct-13 06:58PM  On The Fly: After Hours Movers at theflyonthewall.com -6.93%
04:32PM  GTX INC /DE/ Files SEC form 8-K, Costs Associated with Exit or Disposal Activities, Change in Directors or Principal EDGAR Online
11:18AM  NVIDIA introduces its Battlebox PC program for 4K gaming, powering the LHC at Engadget
10:11AM  NVIDIA introduces its Battlebox PC program for 4K gaming, powering the LHC at Engadget
24-Sep-13 07:30AM  GTx Announces Late Breaker Presentation on Results from the two Phase 3 POWER Trials of enobosarm, a selective androgen receptor modulator (SARM), for the prevention and treatment of muscle wasting in NSCLC patients during 2013 European Can Business Wire +6.16%
16-Sep-13 09:53AM  5 Stocks Ready for Breakouts at TheStreet
13-Sep-13 09:22AM  GTx Inc.: Call Me A Pollyana...Or Not at Seeking Alpha
11-Sep-13 08:57AM  6 Under-$10 Stocks Moving Higher at TheStreet +21.38%
06-Sep-13 07:30AM  GTx Announces Webcast of Corporate Presentation at Stifel Nicolaus 2013 Healthcare Conference Business Wire
30-Aug-13 11:56AM  GTx: 4 Reasons Why This $1 Biotech Stock Could Be Poised For A Big Rebound at Seeking Alpha +13.97%
29-Aug-13 04:02PM  GTx, Inc. Sued by Investor PR Newswire
25-Aug-13 02:15PM  3 Biotech Stocks That May Go to Zero at Motley Fool
07:45AM  5 of Last Week's Biggest Losers at Motley Fool
24-Aug-13 03:16PM  This Week in Biotech at Motley Fool
23-Aug-13 11:20AM  Insiders Buy Shares at Global Partners and GTX at Minyanville +5.07%
10:01AM  Sprint Nextel Corp Part Owner Buys 1M Shares and 4 Insider Buys to Note at Wall St. Cheat Sheet
07:00AM  The 5 Dumbest Things on Wall Street This Week: Aug. 23 at TheStreet
06:00AM  [video] 5 Dumbest Things on Wall Street at TheStreet
21-Aug-13 11:00AM  Pipeline Setback for GTx Zacks
20-Aug-13 09:32PM  Glancy Binkow & Goldberg LLP Announces Investigation of GTx, Inc. Business Wire
06:11PM  Nasdaq stocks posting largest volume increases AP
19-Aug-13 07:01PM  1 Biotech Fast-Tracked to Failure at Motley Fool -65.54%
06:17PM  Nasdaq stocks posting largest volume increases AP
06:17PM  Most active Nasdaq-traded stocks AP
05:15PM  Tata and Dollar General are big market movers AP
04:44PM  Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of GTx Inc. Business Wire
GTx, Inc., a biopharmaceutical company, is engaged in the discovery, development, and commercialization of small molecules for the treatment of cancer, cancer supportive care, and other serious medical conditions. It is involved in developing Enobosarm 3 mg, an androgen receptor modulator, which is in Phase III clinical trial for the prevention and treatment of muscle wasting in patients with non-small cell lung cancer; and Enobosarm 9 mg, which is in Phase II clinical trial for the treatment of AR positive and ER positive metastatic breast cancer in women. The company also develops Capesaris, an oral nonsteroidal estrogen receptor alpha agonist that is in Phase II clinical trial for secondary hormonal therapy in men with metastatic or nonmetastatic castration resistant prostate cancer. GTx, Inc. was founded in 1997 and is headquartered in Memphis, Tennessee.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SCHULER JACK W10% OwnerMar 21Sale1.79638,6391,143,1646,165,261Mar 21 06:31 PM
SCHULER JACK W10% OwnerMar 20Sale1.90115,492219,4356,803,900Mar 21 06:31 PM
SCHULER JACK W10% OwnerMar 19Sale1.91438,120836,8096,919,392Mar 21 06:31 PM
SCHULER JACK W10% OwnerAug 22Buy1.3693,777127,5657,357,512Aug 26 09:16 AM
SCHULER JACK W10% OwnerAug 21Buy1.40199,586278,9617,263,735Aug 22 04:05 PM
SCHULER JACK W10% OwnerAug 20Buy1.45110,005159,5187,064,149Aug 22 04:05 PM
MOSTELLER MARK EDWARDVice President, CFOJul 09Sale7.005,49538,4650Jul 10 05:00 PM
MOSTELLER MARK EDWARDVice President, CFOJul 08Option Exercise6.2417,000106,08017,000Jul 10 05:00 PM
MOSTELLER MARK EDWARDVice President, CFOJul 08Sale6.9811,50580,3055,495Jul 10 05:00 PM